← Back
$RGLS All transactions

Regulus Therapeutics Inc.

▲ BUY
7 / 10

Conviction

$ Value

$96K

Shares

12,000

Price

$8

Filed

Jun 4

Why this score? (7/10)
  • Open market buy (+3)
  • % of holdings >= 20% (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Klassen Preston

Title

President & Head of R & D

CIK

0001493056

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-03

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

48,055

Filing Info

Accession No.

0000950170-25-081715

Form Type

4

Issuer CIK

0001505512

Klassen Preston's History

Date Ticker Type Value
2025-06-25 RGLS D
2025-06-25 RGLS D
2025-06-25 RGLS D
2025-06-25 RGLS D
2025-06-25 RGLS D
2025-06-25 RGLS D
2025-06-03 RGLS $96K

Other Insiders at RGLS (90d)

No other insider activity at this issuer in the last 90 days.